Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

AI-Based Reflective Parenting Simulation for Parents of Autistic Children

7. juli 2026 oppdatert av: University of Haifa

A Randomized Controlled Trial Evaluating an AI-Based Reflective Parenting Simulation for Parents of Autistic Children

This randomized controlled trial evaluates an AI-based parental simulation designed to support reflective parenting, emotional regulation, and parent-child communication among parents of autistic children aged 3 to 12 years. A total of 140 parents will be recruited through an external online survey platform and randomly assigned to an intervention group or a control group. The intervention group will complete baseline questionnaires, engage with the AI-based simulation, and then complete post-intervention measures. The control group will complete baseline and post-assessment measures before receiving access to the simulation.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

The study examines the use of an AI-based parental simulation as a learning and reflective tool for parents of autistic children aged 3 to 12 years. The simulation is designed to allow parents to practice responses to emotionally challenging parent-child situations, with an emphasis on reflective functioning, emotional regulation, playfulness, and supportive parent-child communication.

Participants will be recruited through an external online survey platform and will provide informed consent before participation. After completing baseline questionnaires, participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will complete the AI-based simulation and then complete post-intervention measures. Participants in the control group will complete post-assessment measures before receiving access to the simulation.

Studietype

Intervensjonell

Registrering (Antatt)

140

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • - Parent or primary caregiver of an autistic child aged 3 to 12 years.
  • Child has a parent-reported diagnosis of Autism Spectrum Disorder.
  • Parent is 18 years of age or older.
  • Parent is able to read and complete questionnaires in Hebrew.
  • Parent has access to an internet-connected device and is able to complete the online study procedures.
  • Parent provides informed consent to participate.

Exclusion Criteria:

  • - Parent does not provide informed consent.
  • Parent is not the parent or primary caregiver of an autistic child aged 3 to 12 years.
  • Parent is unable to complete the online questionnaires or the AI-based reflective parenting simulation.
  • Duplicate, incomplete, or low-quality responses that do not meet study quality criteria.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Screening
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Intervention Group
Participants in this group will complete the baseline questionnaire battery, including a study-specific 8-item evaluation questionnaire assessing four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and relational security. They will then engage with the AI-based therapeutic parental simulation and complete the same evaluation questionnaire again, followed by user experience and human-machine interaction questionnaires.
An AI-based reflective parenting simulation designed for parents of autistic children aged 3 to 12 years. The simulation allows parents to practice reflective, emotionally regulated, and supportive responses to challenging parent-child situations, with an emphasis on parent-child communication, shared emotional regulation, and the parent-child relationship as a secure anchor.
Ingen inngripen: Control Group
Participants in this group will complete the baseline questionnaire battery, including a study-specific 8-item evaluation questionnaire assessing four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and relational security. They will then complete the same evaluation questionnaire again before receiving access to the AI-based therapeutic parental simulation. After using the simulation, they will complete user experience and human-machine interaction questionnaires.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Study-Specific Parent Reflective Capacity Questionnaire Score
Tidsramme: Baseline and immediately after the intervention or control assessment point
The study-specific Parent Reflective Capacity Questionnaire includes 8 items rated on a 1 to 5 scale. The questionnaire assesses parents' perceived capacity in four targeted domains: knowledge and understanding, parent-child communication skills, shared emotional regulation, and the parent-child relationship as a secure anchor. A total mean score will be calculated across the 8 items, with higher scores indicating higher perceived parental reflective capacity in the targeted domains.
Baseline and immediately after the intervention or control assessment point

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. juni 2026

Primær fullføring (Antatt)

30. oktober 2026

Studiet fullført (Antatt)

1. juli 2027

Datoer for studieregistrering

Først innsendt

30. juni 2026

Først innsendt som oppfylte QC-kriteriene

30. juni 2026

Først lagt ut (Faktiske)

7. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. juli 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere